Informe
How pre-approval engagement is shaping formulary decision-making
Explore how pre-approval information exchange supports earlier formulary decision-making through payer research and real-world data on timely, sequenced engagement before FDA approval.
Key highlights
This white paper examines how pre-approval information exchange supports earlier formulary decision-making, combining payer research and real-world engagement data to show how timely, sequenced information can improve payer readiness before Food and Drug Administration approval.
